← Leaderboards
Robert Coleman Lindsley
Dana-Farber Cancer Inst
$5,306,772
Attributed
$10,130,878
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–23$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,130,878 · 4
By mechanism
RC2$6,432,141 · 1
P01$2,885,355 · 2
K08$813,382 · 1
Top collaborators
- Maria Eugenia Figueroa5 shared
- Mark D Fleming5 shared
- Akiko Shimamura5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Benjamin Levine Ebert$26,802,844
- Pietro Genovese$5,128,749
- Anupama Narla$773,118
- Alyssa Kennedy$742,865
- David S Pellman$18,057,380
Others in their field
Top investigators on “Biology”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologyCohortCellsHematopoiesisSamplingMutationTechnologyGeneticEpigenetic ProcessMyeloproliferative DiseaseTranscriptomicsTranscriptomeProductionClonal EvolutionHematopoietic Stem CellsHigh RiskHematopoieticInnovationLeukemiaDysmyelopoietic SyndromesGenesAcute Myelocytic LeukemiaAffectDisease Progression
Grant awards (15)
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2023 · DK
Defining the scope and clinical impact of donor CHIP after allogeneic HCT$568,893
P01 · FY2023 · CA · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2022 · DK
Defining the scope and clinical impact of donor CHIP after allogeneic HCT$565,186
P01 · FY2022 · CA · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2021 · DK
Defining the scope and clinical impact of donor CHIP after allogeneic HCT$576,720
P01 · FY2021 · CA · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,278,845
RC2 · FY2020 · DK
Defining the scope and clinical impact of donor CHIP after allogeneic HCT$577,528
P01 · FY2020 · CA · contact PI
Determining the Role of BCOR Mutations in Myeloid Malignancies$141,236
K08 · FY2020 · CA · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,340,212
RC2 · FY2019 · DK
Defining the scope and clinical impact of donor CHIP after allogeneic HCT$597,028
P01 · FY2019 · CA · contact PI
Determining the Role of BCOR Mutations in Myeloid Malignancies$141,236
K08 · FY2019 · CA · contact PI
Determining the Role of BCOR Mutations in Myeloid Malignancies$176,970
K08 · FY2018 · CA · contact PI
Determining the Role of BCOR Mutations in Myeloid Malignancies$176,970
K08 · FY2017 · CA · contact PI
Determining the Role of BCOR Mutations in Myeloid Malignancies$176,970
K08 · FY2016 · CA · contact PI